Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema
- 30 March 2002
- Vol. 324 (7340) , 768
- https://doi.org/10.1136/bmj.324.7340.768
Abstract
Objective: To determine whether a three day burst of a potent corticosteroid is more effective than a mild preparation used for seven days in children with mild or moderate atopic eczema. Design: Randomised, double blind, parallel group study of 18 weeks' duration. Setting: 13 general practices and a teaching hospital in the Nottingham area. Participants: 174 children with mild or moderate atopic eczema recruited from general practices and 33 from a hospital outpatient clinic. Interventions: 0.1% betamethasone valerate applied for three days followed by the base ointment for four days versus 1% hydrocortisone applied for seven days. Main outcome measures: Primary outcomes were total number of scratch-free days and number of relapses. Secondary outcomes were median duration of relapses, number of undisturbed nights, disease severity (six area, six sign atopic dermatitis severity scale), scores on two quality of life measures (children's life quality index and dermatitis family impact questionnaire), and number of patients in whom treatment failed in each arm. Results: No differences were found between the two groups. This was consistent for all outcomes. The median number of scratch-free days was 118.0 for the mild group and 117.5 for the potent group (difference 0.5, 95% confidence interval −2.0 to 4.0, P=0.53). The median number of relapses for both groups was 1.0. Both groups showed clinically important improvements in disease severity and quality of life compared with baseline. Conclusion: A short burst of a potent topical corticosteroid is just as effective as prolonged use of a milder preparation for controlling mild or moderate atopic eczema in children. What is already known on this topic Topical corticosteroids have been used to control atopic eczema for 40 years No studies have compared short bursts of a potent preparation with prolonged use of a weak preparation for controlling mild or moderate disease What this study adds A short burst of a potent topical steroid is as effective and safe as prolonged use of a weak preparation for mild or moderate atopic eczema The type of preparation is immaterial provided that the dosage is adequateKeywords
This publication has 15 references indexed in Scilit:
- Dermal fluid translocation is an important determinant of the diurnal variation in human skin thicknessBritish Journal of Dermatology, 2001
- The natural history of atopic dermatitisPublished by Cambridge University Press (CUP) ,2000
- The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionateBritish Journal of Dermatology, 1999
- The family impact of childhood atopic dermatitis: the Dermatitis Family Impact questionnaireBritish Journal of Dermatology, 1998
- A 3‐Day Rate of Efficacy of a Moderate Potency Topical Steroid in the Treatment of Atopic Dermatitis in Infancy and ChildhoodPediatric Dermatology, 1996
- Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis*British Journal of Dermatology, 1996
- A Reappraisal of Topical Steroid PotencyPediatric Dermatology, 1996
- Fortnightly Review: Management of atopic eczemaBMJ, 1995
- The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis..British Journal of Dermatology, 1994
- Guidelines for Topical Treatment in Atopic EczemaPublished by Springer Nature ,1991